|
|
Legal status
Patent not validated
| (51) | INT.CL. | A01N 43/42 | |
| A61K 31/44 | |||
| A61P 25/18 | |||
| A61P 25/24 | |||
| A61P 25/14 | |||
| A61P 25/20 | |||
| C07D 471/14 |
| (11) | Number of the document | 2836213 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13776297.7 |
| Date of filing the European patent application | 2013-04-14 | |
| (97) | Date of publication of the European application | 2015-02-18 |
| (45) | Date of publication and mention of the grant of the patent | 2018-07-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/036514 |
| Date | 2013-04-14 |
| (87) | Number | WO 2013/155505 |
| Date | 2013-10-17 |
| (30) | Number | Date | Country code |
| 201261624293 P | 2012-04-14 | US | |
| 201261624292 P | 2012-04-14 | US | |
| 201261624291 P | 2012-04-14 | US | |
| 201261671723 P | 2012-07-14 | US | |
| 201261671713 P | 2012-07-14 | US |
| (72) |
MATES, Sharon, US
DAVIS, Robert, US
LI, Peng, US
WENNOGLE, Lawrence, US
LERNER, Richard A., US
|
| (73) |
Intra-Cellular Therapies, Inc.,
430 East 29th Street, Suite 900, New York, NY 10016,
US
|
| (54) | FUSED GAMMA CARBOLINES |
| FUSED GAMMA CARBOLINES |